Back to search

Article

Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: data from the DA-COVID-19 registry Running title: AD management during COVID-19 pandemic

2021-01-21

Abstract excerpt

<h4>Background: </h4>  Few and small studies have described the management of immunomodulant/immunosuppressive therapies or phototherapy in atopic dermatitis (AD) patients during coronavirus disease 2019 (COVID-19) pandemic.  <h4>Methods: </h4>:  A national registry, named DA-COVID-19 and involving 35 Italian dermatology units, was established in order to evaluate the impact of COVID-19 pandemic on the management...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
abd87c6c-f1e9-521a-8d7d-a295d4a70857
DOI
10.22541/au.161127068.82018644/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: data from the DA-COVID-19 registry Running title: AD management during COVID-19 pandemicDOI 10.22541/au.161127068.82018644/v1
Select a neighboring publication to make it the new centre.